20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension

Yan Ding, Cheng Chia Wu, Victor Garcia, Irina Dimitrova, Adam Weidenhammer, Gregory Joseph, Frank Zhang, Vijay L. Manthati, J R Falck, Jorge H. Capdevila, Michal L. Schwartzman

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P-450 (Cyp)-derived arachidonic acid metabolite that has been shown to increase smooth muscle contractions and proliferation, stimulate endothelial dysfunction and activation, and promote hypertension. We examined if 20-HETE contributes to microvascular remodeling in hypertension. In Sprague-Dawley rats, administration of the 20-HETE biosynthesis inhibitor HET0016 or the 20-HETE antagonist N-20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (20- HEDE) prevented 5α-dihydrotestosterone (DHT)-induced increases in blood pressure as well as abrogated DHT-induced increases in the media-to-lumen ratio (M/L), media thickness, and collagen IV deposition in renal interlobar arteries. Reserpine prevented blood pressure elevation in DHT-treated rats but did not affect microvascular remodeling (M/L, media thickness, and collagen deposition); under these conditions, treatment with the 20-HETE antagonist attenuated microvascular remodeling, suggesting that 20-HETE contributes to DHT-induced vascular remodeling independent of blood pressure elevation. In Cyp4a14-/- mice, which display androgen-driven and 20-HETE-dependent hypertension, treatment with the 20-HETE antagonist abolished remodeling of renal resistance arteries measured as media thickness (24 ±1 vs. 15 ± 1 μm) and M/L (0.29±0.03 vs. 0.17±0.01). Moreover, in Cyp4a12 transgenic mice in which the expression of Cyp4a12-20-HETE synthase is driven by a tetracycline-sensitive promoter, treatment with doxycycline resulted in blood pressure elevation (140 ± 4 vs. 92 ± 5 mmHg) and a significant increase in remodeling of renal resistance arteries (media thickness: 23 ±1 vs. 16 ± 1 μm; M/L: 0.39 ±0.04 vs. 0.23 ± 0.02); these increases were abrogated by cotreatment with 20-HEDE. This study demonstrated that 20-HETE is a key regulator of microvascular remodeling in hypertension; its effect is independent of blood pressure elevation and androgen levels.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Renal Physiology
Volume305
Issue number5
DOIs
StatePublished - Sep 1 2013

Fingerprint

Renal Artery
Blood Pressure
Hypertension
Dihydrotestosterone
Androgens
Collagen
20-hydroxy-5,8,11,14-eicosatetraenoic acid
Doxycycline
Reserpine
Muscle Contraction
Tetracycline
Arachidonic Acid
Cytochrome P-450 Enzyme System
Transgenic Mice
Smooth Muscle
Sprague Dawley Rats

Keywords

  • 20-hydroxyeicosatetraenoic acid
  • Androgen
  • Blood pressure
  • Cytochrome P-450 4A

ASJC Scopus subject areas

  • Physiology
  • Urology

Cite this

20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension. / Ding, Yan; Wu, Cheng Chia; Garcia, Victor; Dimitrova, Irina; Weidenhammer, Adam; Joseph, Gregory; Zhang, Frank; Manthati, Vijay L.; Falck, J R; Capdevila, Jorge H.; Schwartzman, Michal L.

In: American Journal of Physiology - Renal Physiology, Vol. 305, No. 5, 01.09.2013.

Research output: Contribution to journalArticle

Ding, Y, Wu, CC, Garcia, V, Dimitrova, I, Weidenhammer, A, Joseph, G, Zhang, F, Manthati, VL, Falck, JR, Capdevila, JH & Schwartzman, ML 2013, '20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension', American Journal of Physiology - Renal Physiology, vol. 305, no. 5. https://doi.org/10.1152/ajprenal.00292.2013
Ding, Yan ; Wu, Cheng Chia ; Garcia, Victor ; Dimitrova, Irina ; Weidenhammer, Adam ; Joseph, Gregory ; Zhang, Frank ; Manthati, Vijay L. ; Falck, J R ; Capdevila, Jorge H. ; Schwartzman, Michal L. / 20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension. In: American Journal of Physiology - Renal Physiology. 2013 ; Vol. 305, No. 5.
@article{eea39f94799a4cbb82fada821ea9787d,
title = "20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension",
abstract = "20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P-450 (Cyp)-derived arachidonic acid metabolite that has been shown to increase smooth muscle contractions and proliferation, stimulate endothelial dysfunction and activation, and promote hypertension. We examined if 20-HETE contributes to microvascular remodeling in hypertension. In Sprague-Dawley rats, administration of the 20-HETE biosynthesis inhibitor HET0016 or the 20-HETE antagonist N-20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (20- HEDE) prevented 5α-dihydrotestosterone (DHT)-induced increases in blood pressure as well as abrogated DHT-induced increases in the media-to-lumen ratio (M/L), media thickness, and collagen IV deposition in renal interlobar arteries. Reserpine prevented blood pressure elevation in DHT-treated rats but did not affect microvascular remodeling (M/L, media thickness, and collagen deposition); under these conditions, treatment with the 20-HETE antagonist attenuated microvascular remodeling, suggesting that 20-HETE contributes to DHT-induced vascular remodeling independent of blood pressure elevation. In Cyp4a14-/- mice, which display androgen-driven and 20-HETE-dependent hypertension, treatment with the 20-HETE antagonist abolished remodeling of renal resistance arteries measured as media thickness (24 ±1 vs. 15 ± 1 μm) and M/L (0.29±0.03 vs. 0.17±0.01). Moreover, in Cyp4a12 transgenic mice in which the expression of Cyp4a12-20-HETE synthase is driven by a tetracycline-sensitive promoter, treatment with doxycycline resulted in blood pressure elevation (140 ± 4 vs. 92 ± 5 mmHg) and a significant increase in remodeling of renal resistance arteries (media thickness: 23 ±1 vs. 16 ± 1 μm; M/L: 0.39 ±0.04 vs. 0.23 ± 0.02); these increases were abrogated by cotreatment with 20-HEDE. This study demonstrated that 20-HETE is a key regulator of microvascular remodeling in hypertension; its effect is independent of blood pressure elevation and androgen levels.",
keywords = "20-hydroxyeicosatetraenoic acid, Androgen, Blood pressure, Cytochrome P-450 4A",
author = "Yan Ding and Wu, {Cheng Chia} and Victor Garcia and Irina Dimitrova and Adam Weidenhammer and Gregory Joseph and Frank Zhang and Manthati, {Vijay L.} and Falck, {J R} and Capdevila, {Jorge H.} and Schwartzman, {Michal L.}",
year = "2013",
month = "9",
day = "1",
doi = "10.1152/ajprenal.00292.2013",
language = "English (US)",
volume = "305",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - 20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension

AU - Ding, Yan

AU - Wu, Cheng Chia

AU - Garcia, Victor

AU - Dimitrova, Irina

AU - Weidenhammer, Adam

AU - Joseph, Gregory

AU - Zhang, Frank

AU - Manthati, Vijay L.

AU - Falck, J R

AU - Capdevila, Jorge H.

AU - Schwartzman, Michal L.

PY - 2013/9/1

Y1 - 2013/9/1

N2 - 20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P-450 (Cyp)-derived arachidonic acid metabolite that has been shown to increase smooth muscle contractions and proliferation, stimulate endothelial dysfunction and activation, and promote hypertension. We examined if 20-HETE contributes to microvascular remodeling in hypertension. In Sprague-Dawley rats, administration of the 20-HETE biosynthesis inhibitor HET0016 or the 20-HETE antagonist N-20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (20- HEDE) prevented 5α-dihydrotestosterone (DHT)-induced increases in blood pressure as well as abrogated DHT-induced increases in the media-to-lumen ratio (M/L), media thickness, and collagen IV deposition in renal interlobar arteries. Reserpine prevented blood pressure elevation in DHT-treated rats but did not affect microvascular remodeling (M/L, media thickness, and collagen deposition); under these conditions, treatment with the 20-HETE antagonist attenuated microvascular remodeling, suggesting that 20-HETE contributes to DHT-induced vascular remodeling independent of blood pressure elevation. In Cyp4a14-/- mice, which display androgen-driven and 20-HETE-dependent hypertension, treatment with the 20-HETE antagonist abolished remodeling of renal resistance arteries measured as media thickness (24 ±1 vs. 15 ± 1 μm) and M/L (0.29±0.03 vs. 0.17±0.01). Moreover, in Cyp4a12 transgenic mice in which the expression of Cyp4a12-20-HETE synthase is driven by a tetracycline-sensitive promoter, treatment with doxycycline resulted in blood pressure elevation (140 ± 4 vs. 92 ± 5 mmHg) and a significant increase in remodeling of renal resistance arteries (media thickness: 23 ±1 vs. 16 ± 1 μm; M/L: 0.39 ±0.04 vs. 0.23 ± 0.02); these increases were abrogated by cotreatment with 20-HEDE. This study demonstrated that 20-HETE is a key regulator of microvascular remodeling in hypertension; its effect is independent of blood pressure elevation and androgen levels.

AB - 20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P-450 (Cyp)-derived arachidonic acid metabolite that has been shown to increase smooth muscle contractions and proliferation, stimulate endothelial dysfunction and activation, and promote hypertension. We examined if 20-HETE contributes to microvascular remodeling in hypertension. In Sprague-Dawley rats, administration of the 20-HETE biosynthesis inhibitor HET0016 or the 20-HETE antagonist N-20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (20- HEDE) prevented 5α-dihydrotestosterone (DHT)-induced increases in blood pressure as well as abrogated DHT-induced increases in the media-to-lumen ratio (M/L), media thickness, and collagen IV deposition in renal interlobar arteries. Reserpine prevented blood pressure elevation in DHT-treated rats but did not affect microvascular remodeling (M/L, media thickness, and collagen deposition); under these conditions, treatment with the 20-HETE antagonist attenuated microvascular remodeling, suggesting that 20-HETE contributes to DHT-induced vascular remodeling independent of blood pressure elevation. In Cyp4a14-/- mice, which display androgen-driven and 20-HETE-dependent hypertension, treatment with the 20-HETE antagonist abolished remodeling of renal resistance arteries measured as media thickness (24 ±1 vs. 15 ± 1 μm) and M/L (0.29±0.03 vs. 0.17±0.01). Moreover, in Cyp4a12 transgenic mice in which the expression of Cyp4a12-20-HETE synthase is driven by a tetracycline-sensitive promoter, treatment with doxycycline resulted in blood pressure elevation (140 ± 4 vs. 92 ± 5 mmHg) and a significant increase in remodeling of renal resistance arteries (media thickness: 23 ±1 vs. 16 ± 1 μm; M/L: 0.39 ±0.04 vs. 0.23 ± 0.02); these increases were abrogated by cotreatment with 20-HEDE. This study demonstrated that 20-HETE is a key regulator of microvascular remodeling in hypertension; its effect is independent of blood pressure elevation and androgen levels.

KW - 20-hydroxyeicosatetraenoic acid

KW - Androgen

KW - Blood pressure

KW - Cytochrome P-450 4A

UR - http://www.scopus.com/inward/record.url?scp=84883443928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883443928&partnerID=8YFLogxK

U2 - 10.1152/ajprenal.00292.2013

DO - 10.1152/ajprenal.00292.2013

M3 - Article

VL - 305

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 5

ER -